| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GARS mRNA | affects expression | 21346803
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GARS mRNA | affects expression | 21346803
|
| C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of GARS mRNA | affects expression | 21346803
|
| D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of GARS protein | affects expression | 20106945
|
| C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of GARS mRNA | increases expression | 20458559
|
| D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of GARS mRNA | decreases expression | 20106945
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of GARS mRNA | decreases expression | 20018196
|
| C095105 |
bexarotene |
bexarotene results in decreased expression of GARS mRNA | decreases expression | 17178900
|
| D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of GARS mRNA | decreases expression | 15003993
|
| D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of GARS mRNA | affects cotreatment|affects expression | 17602206
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of GARS mRNA | increases expression | 20106945
|
| D002945 |
Cisplatin |
GARS protein affects the susceptibility to Cisplatin | affects response to substance | 16217747
|
| D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine] results in increased expression of GARS mRNA | affects cotreatment|increases expression | 15784690
|
| D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of GARS mRNA | affects cotreatment|affects expression | 17602206
|
| D004958 |
Estradiol |
Estradiol results in increased expression of GARS mRNA | increases expression | 20106945
|
| D015525 |
Fatty Acids, Omega-3 |
Fatty Acids, Omega-3 results in decreased expression of GARS mRNA | decreases expression | 16823509
|
| C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of GARS mRNA | increases expression | 16221962
|
| C419708 |
gefitinib |
gefitinib results in increased expression of GARS mRNA | increases expression | 16685379
|
| D043371 |
Fatty Acids, Omega-6 |
Fatty Acids, Omega-6 results in decreased expression of GARS mRNA | decreases expression | 16823509
|
| D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of GARS mRNA] | affects reaction|increases expression | 19482888
|
| D010634 |
Phenobarbital |
Phenobarbital results in increased expression of GARS mRNA | increases expression | 19482888
|
| D011374 |
Progesterone |
Progesterone results in increased expression of GARS mRNA | increases expression | 18037150
|
| D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of GARS mRNA | increases expression | 18175754
|
| C025462 |
sulindac sulfide |
sulindac sulfide results in increased expression of GARS mRNA | increases expression | 12734198
|
| D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GARS mRNA | decreases expression | 20106945
|
| D014212 |
Tretinoin |
Tretinoin results in decreased expression of GARS mRNA | decreases expression | 16140955
|
| D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine] results in increased expression of GARS mRNA | affects cotreatment|increases expression | 15784690
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
13.04 | 7525203 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
13.04 | 6195326 |
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
13.04 | 15322242 11752688 14514962 |
| MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.62 | 9612607 |
| MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.77 | 15814532 17670903 12690470 |
| MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
9.74 | 11798837 19825857 |
| MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.74 | 20127859 20464547 |
| MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
9.74 | 17638652 11798837 |
| MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.74 | 11473722 |
| MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.23 | 6695378 |
| MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.23 | 6695378 10737359 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
16.12 | 17162532 19061943 16434500 19052882 17620307 18056438 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
16.12 | 17620307 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
16.12 | 16835633 |
| MESH:D000505 |
Alopecia |
|
Tretinoin |
3.45 | 15955085 |
| MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
3.04 | 18759972 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.76 | 11748828 |
| MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.87 | 19183758 |
| MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.95 | 16412693 |
| MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.22 | 16292516 |
| MESH:D001249 |
Asthma |
|
Tretinoin |
2.28 | 16456186 |
| MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-3 |
8.80 | 18448859 |
| MESH:D001289 |
Attention Deficit Disorder with Hyperactivity |
|
Fatty Acids, Omega-6 |
8.80 | 18448859 |
| MESH:D001321 |
Autistic Disorder |
|
Fatty Acids, Omega-3 |
3.50 | 16920077 |
| MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.20 | 16935849 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
14.24 | 16206674 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.24 | 12125929 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.24 | 16206674 16197459 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.58 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.63 | 15746008 |
| MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.67 | 14601052 |
| MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.13 | 17868700 |
| MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.05 | 15665606 15845082 15380490 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
4.56 | 17474063 20146248 |
| MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
4.56 | 16344269 16818667 |
| MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
4.56 | 19526202 18382427 |
| MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
4.56 | 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.56 | 12948864 16675129 17289903 17261762 19861407 14630087 18497071 17018787 |
| MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
4.56 | 17614352 15562024 16175315 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.56 | 20435547 |
| MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
4.56 | 16166294 16443354 16873071 |
| MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.38 | 16813970 |
| MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.13 | 11589617 |
| MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.25 | 16111702 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.63 | 16835633 |
| MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.95 | 16168501 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
19.23 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
19.23 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
19.23 | 21507988 12907637 12619106 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
19.23 | 11135700 14691202 15553829 16217749 15073043 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
19.23 | 17982673 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
19.23 | 16698587 10672840 19418558 17173139 20101231 16569478 17162532 18393292 16540662 17978847 19383236 20727157 19107877 18210153 20524982 19701751 20432363 16502159 18494052 19052882 21159647 16288022 16681979 19919837 18691550 19208518 18056438 16935385 16830150 17138121 16779866 19171122 19822196 20214788 18971187 16878318 3581430 16328049 10737359 17055752 19335982 20514400 18665156 18978308 20007298 19539802 20512989 17761372 3084413 18506893 17428255 18788625 19394651 16807293 20084675 11831363 18785209 19519916 20935162 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
19.23 | 16924424 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
19.23 | 20935162 20007298 6705139 1701930 17173139 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
19.23 | 1917145 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
12.27 | 16247446 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
12.27 | 12023789 16685392 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
gefitinib |
12.27 | 16230376 15496427 19233551 20005069 18347146 17290066 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
12.27 | 12391285 |
| MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.66 | 19014326 |
| MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.93 | 12490120 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.20 | 20419170 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
7.20 | 17066447 18337622 6189445 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.20 | 16051514 16096774 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.25 | 18850075 18670907 16120746 |
| MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
7.21 | 14694615 |
| MESH:D002386 |
Cataract |
|
Tretinoin |
7.21 | 17460283 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
19.56 | 6135515 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
19.56 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
19.56 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
19.56 | 2727394 21159647 17174075 7505956 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
19.56 | 18566989 |
| MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
4.04 | 4080065 |
| MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.38 | 16129372 |
| MESH:C537993 |
Charcot-Marie-Tooth disease, Type 2D |
marker/mechanism |
|
| |
| MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
8.74 | 19052882 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
8.74 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.76 | 19486331 |
| MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.95 | 16461808 |
| MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.54 | 15894690 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.47 | 15668235 8697196 16354765 15340226 12621046 |
| MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.47 | 9407595 |
| MESH:D003092 |
Colitis |
|
Tretinoin |
3.50 | 17035595 |
| MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.56 | 20501625 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
3.56 | 15273666 |
| MESH:D015179 |
Colorectal Neoplasms |
|
gefitinib |
3.56 | 17594712 |
| MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
8.60 | 15095906 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.60 | 17141729 14669216 |
| MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.98 | 12609071 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.63 | 10525206 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.63 | 10048152 15322242 20055451 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.63 | 9125849 16925845 9664655 17551590 14991402 10589399 9142499 9211117 8800419 9224671 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.20 | 18551238 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.20 | 18551238 |
| MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.90 | 15213294 |
| MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.60 | 16285004 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.04 | 20387270 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.04 | 17107852 |
| MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.24 | 19279558 |
| MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.28 | 17187935 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
17.71 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
17.71 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
17.71 | 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
17.71 | 19107877 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
17.71 | 16221962 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
17.71 | 15131321 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
17.71 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
18.41 | 12649298 12231392 19839026 15033597 |
| MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
18.41 | 15040536 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
18.41 | 11462148 |
| MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
18.41 | 15040536 |
| MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.81 | 1851702 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.20 | 11000095 12711302 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.23 | 16714409 15322242 18230668 |
| MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.23 | 18230668 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.58 | 17692515 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.96 | 11473722 18566989 19148513 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
6.96 | 16569247 |
| MESH:D004715 |
Endometriosis |
|
Progesterone |
8.32 | 16134523 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.32 | 9294722 10568697 |
| MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.90 | 3659116 |
| MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.66 | 3922381 11558140 |
| MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.78 | 20417680 |
| MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.37 | 6401628 |
| MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
4.04 | 7750514 |
| MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.81 | 3659116 |
| MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.90 | 16302075 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.95 | 20426865 |
| MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
9.95 | 12903497 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
9.95 | 16530937 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
9.95 | 17638652 15464296 16481741 15173087 16785472 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.32 | 11564622 |
| MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.32 | 16938888 9664655 |
| MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
17.26 | 15073043 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
17.26 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
17.26 | 21071580 20387270 |
| MESH:D005234 |
Fatty Liver |
|
Zidovudine |
17.26 | 18299183 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.25 | 11858732 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.52 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.52 | 20067830 |
| MESH:D005355 |
Fibrosis |
|
Tretinoin |
13.52 | 17994277 |
| MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.06 | 16904648 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.01 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.87 | 17312396 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.38 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
7.45 | 15464296 15102660 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.45 | 16096774 |
| MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.12 | 19898482 |
| MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.95 | 16084493 |
| MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.25 | 15464296 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.46 | 20471113 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.46 | 10048152 11294989 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.46 | 14991402 9664655 |
| MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.52 | 12579204 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.21 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.15 | 11000095 |
| MESH:D006509 |
Hepatitis B |
|
Lamivudine |
4.91 | 17703166 |
| MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
4.91 | 12044531 16476009 15274664 15631357 15309715 |
| MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
13.35 | 16221962 |
| MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
13.35 | 16109766 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.35 | 16120746 15340226 12621046 |
| MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.82 | 15709030 |
| MESH:D015658 |
HIV Infections |
|
Lamivudine |
6.70 | 20032539 11141242 17530837 9296927 |
| MESH:D015658 |
HIV Infections |
|
Zidovudine |
6.70 | 11698656 11141242 20032539 17358032 11363243 |
| MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.42 | 16200630 16170182 |
| MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.54 | 17088409 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.83 | 15340226 16959395 8697196 18606429 16354765 |
| MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.05 | 16870215 |
| MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.36 | 16778211 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.68 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.68 | 18670907 18850075 |
| MESH:D006976 |
Hypertension, Pulmonary |
|
gefitinib |
4.55 | 18424623 |
| MESH:D017380 |
Hypertrophy, Right Ventricular |
|
gefitinib |
6.02 | 18424623 |
| MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.19 | 15869954 |
| MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
11.13 | 18785209 |
| MESH:D007249 |
Inflammation |
|
Fatty Acids, Omega-3 |
11.13 | 17296493 |
| MESH:D007249 |
Inflammation |
|
Progesterone |
11.13 | 15869954 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.13 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.98 | 16627594 16393666 |
| MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
6.98 | 14714311 |
| MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.56 | 17994277 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.30 | 16580747 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.30 | 15992940 17551590 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.23 | 15604871 |
| MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.93 | 15464296 |
| MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
9.42 | 15190930 12649298 12231392 19839026 18289764 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
9.42 | 18776723 10903974 8314463 |
| MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.42 | 15618244 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
26.90 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
26.90 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
26.90 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
26.90 | 15610895 |
| MESH:D007680 |
Kidney Neoplasms |
|
gefitinib |
26.90 | 18625569 |
| MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
26.90 | 12579204 |
| MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.58 | 11231351 |
| MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.00 | 15070760 |
| MESH:D007938 |
Leukemia |
|
Tretinoin |
6.00 | 17143497 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
9.21 | 12560223 17077332 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
9.21 | 20370541 |
| MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.10 | 16972261 |
| MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.27 | 14633726 |
| MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
8.84 | 19077051 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.84 | 16482212 16932348 19285840 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.75 | 16467208 16968895 17050201 20471514 19850784 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.75 | 19850784 17596541 16294345 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.18 | 16112521 17649720 19075265 15748426 11468182 19225113 16823087 12018890 17107899 17217047 19035177 11161223 9834237 15213294 12712474 16891316 16331271 17869043 17712046 15336539 19642359 16966277 15622746 16330433 12679006 |
| MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.18 | 17217047 19029980 16140955 15748426 19642359 16766008 17339181 12679006 17107899 16331271 17712046 17368321 16891316 16788101 17649720 17506722 19035177 19225113 17294898 16935935 16823087 19075265 17361223 17301526 9834237 |
| MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.15 | 16882451 |
| MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.16 | 9224671 |
| MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.26 | 18522880 19638242 18665156 18407596 20032147 |
| MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.26 | 21047994 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.30 | 14716833 14659978 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.30 | 12878042 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.30 | 16248980 18397230 |
| MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
3.92 | 17034775 |
| MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
3.92 | 19363144 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
24.57 | 7678174 |
| MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
24.57 | 9163691 15890375 2125692 18177683 |
| MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
24.57 | 14682389 |
| MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
24.57 | 20195826 21137059 |
| MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
24.57 | 17602206 |
| MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
24.57 | 2862719 20501860 21278145 20583210 19690152 20118626 20101389 18978307 20137499 19427195 21071580 19255062 21167192 15885732 18648771 19833225 12771043 19073162 12112319 2422723 19638242 19996281 19254457 19090486 18754104 19850985 15175105 16942905 19294768 21047994 19499222 20434301 20452335 19551842 19812893 20405173 18977376 18644402 19426721 9163691 19642983 20492335 19256749 10737359 |
| MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
24.57 | 19812893 15975961 8742319 21047994 19482888 19073162 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
24.57 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
21.68 | 2876784 2876786 6135515 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
21.68 | 8603461 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
21.68 | 20377131 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
21.68 | 3124819 9362446 16842330 16267830 18093689 18079962 19126423 19009564 17174075 18308698 21159647 19539802 18164116 18544905 18253720 18775883 19519916 17942915 18282651 17854601 2563599 19004024 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
21.68 | 17172636 1399818 6150874 18308698 2563599 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
21.68 | 12151625 |
| MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.19 | 15213294 |
| MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
12.53 | 14755239 |
| MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
12.53 | 19825857 11798837 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
12.53 | 20464547 17053015 18569708 20135361 18816296 18520028 20869020 6695378 20064080 |
| MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
12.53 | 17849452 |
| MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
12.53 | 11798837 6189445 17225452 |
| MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
12.53 | 6695378 20970405 21163286 20512841 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
12.53 | 11884234 19555203 |
| MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
12.53 | 18800350 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.86 | 14737004 |
| MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
4.94 | 11161223 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
13.28 | 15591091 19196723 19196722 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
13.28 | 17203775 11408345 16891317 11807958 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
gefitinib |
13.28 | 18375820 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
13.28 | 11408345 17203775 |
| MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.27 | 19453300 |
| MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.70 | 17453147 |
| MESH:D008545 |
Melanoma |
|
Cisplatin |
3.38 | 12374674 16809738 18176117 16248763 11135225 17761969 12393984 15577323 12883367 16432458 17023156 18505091 18332650 |
| MESH:D008545 |
Melanoma |
|
Tretinoin |
3.38 | 16752155 |
| MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
4.56 | 15990972 |
| MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.22 | 16940565 |
| MESH:D008654 |
Mesothelioma |
|
Cisplatin |
3.16 | 17638057 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.58 | 16801185 |
| MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.63 | 17358032 |
| MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.03 | 16381670 |
| MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
2.96 | 15949261 14977855 19417148 19549372 11468182 |
| MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.46 | 18349030 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.00 | 16105982 16882451 |
| MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.00 | 17596541 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.85 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.12 | 16810080 |
| MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.26 | 17484760 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.64 | 18551238 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.64 | 7678174 18551238 |
| MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.76 | 16624393 |
| MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.48 | 3581430 9029167 |
| MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.72 | 11141357 |
| MESH:D009369 |
Neoplasms |
|
Cisplatin |
7.72 | 16773208 |
| MESH:D009369 |
Neoplasms |
|
Tretinoin |
7.72 | 16946489 16594593 |
| MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
4.57 | 19196722 |
| MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.52 | 17289903 |
| MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.28 | 15464296 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.23 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.11 | 19348381 18481113 |
| MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.16 | 11399458 16427766 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.16 | 14600291 |
| MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.16 | 9125849 |
| MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
6.85 | 10525206 |
| MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.85 | 9142499 |
| MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.34 | 8761367 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.17 | 20387270 |
| MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.49 | 8761367 |
| MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.90 | 20387270 |
| OMIM:600794 |
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE V |
marker/mechanism |
|
| |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
14.10 | 16049721 12819281 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
14.10 | 16049721 |
| MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
14.10 | 14694615 |
| MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.15 | 17016548 |
| MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
14.27 | 16624393 19769630 12452020 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
14.27 | 17225452 19769630 6897625 15464296 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.27 | 19401270 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
14.27 | 16525653 17393432 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
14.27 | 16936753 |
| MESH:D010146 |
Pain |
|
Tretinoin |
2.74 | 16870215 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
15.51 | 15580305 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
15.51 | 19003803 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
15.51 | 16540662 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
15.51 | 16965848 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
15.51 | 15976015 |
| MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.97 | 19927285 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.04 | 12520081 |
| MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.11 | 15464296 |
| MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.13 | 17638057 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.36 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
14.25 | 12371664 |
| MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
14.25 | 2563599 |
| MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
14.25 | 2563599 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
2.98 | 11118676 11896295 11222880 11399792 |
| MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.69 | 20887781 |
| MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.89 | 19131511 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.89 | 17292933 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.89 | 16740699 |
| MESH:D011471 |
Prostatic Neoplasms |
|
gefitinib |
1.89 | 15651060 17914592 16685379 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
1.89 | 18760546 |
| MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.41 | 16636307 |
| MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.28 | 12752131 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.16 | 16882103 |
| MESH:D011625 |
Pterygium |
|
Tretinoin |
4.58 | 16723453 |
| MESH:D011658 |
Pulmonary Fibrosis |
|
gefitinib |
3.93 | 18424623 |
| MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.20 | 15464296 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.64 | 18990726 |
| MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
5.32 | 9296927 |
| MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.90 | 16283617 16116481 |
| MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.78 | 18045962 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
9.67 | 16646077 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
9.67 | 14601052 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
8.99 | 18551238 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
8.99 | 18551238 |
| MESH:D012640 |
Seizures |
|
Phenobarbital |
8.99 | 11442880 16876388 3137016 4039156 |
| MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.61 | 6407741 |
| MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.73 | 19755658 10029692 |
| MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
12.73 | 8532709 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.73 | 16192470 |
| MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
12.73 | 16467112 |
| MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.13 | 15464296 |
| MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.07 | 16503802 15862959 |
| MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
8.02 | 17007042 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
8.02 | 20155912 2093021 |
| MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
8.02 | 15958060 17522103 18396642 |
| MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
8.02 | 18456281 |
| MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
8.02 | 17261132 |
| MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
8.02 | 17696246 |
| MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.43 | 15464296 17225452 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.69 | 12697716 |
| MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
20.81 | 19014326 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
20.81 | 7505956 |
| MESH:D013964 |
Thyroid Neoplasms |
|
gefitinib |
20.81 | 16940797 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
20.81 | 1399818 |
| MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
20.81 | 16026305 17045167 |
| MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.47 | 19048282 |
| MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.60 | 16051514 |
| MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.75 | 15213294 |
| MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.10 | 16040207 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
14.92 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
14.92 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
14.92 | 12973940 12845720 11780464 20435036 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
14.92 | 17053015 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
14.92 | 17225452 15464296 12973940 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
11.28 | 10091137 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
11.28 | 10091137 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
8.96 | 16803524 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.96 | 16129372 |
| MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
4.45 | 18645019 |
| MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.40 | 16752155 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.77 | 1336536 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
10.51 | 15577323 |
| MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
10.51 | 12579204 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.38 | 12125929 |
| MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.85 | 16761959 |
| MESH:D014839 |
Vomiting |
|
Cisplatin |
4.51 | 11897121 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.04 | 15886252 |
| MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.79 | 16287080 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.23 | 17120751 |